EP0705108A4 - Cryptic peptides for use in inducing immunologic tolerance - Google Patents
Cryptic peptides for use in inducing immunologic toleranceInfo
- Publication number
- EP0705108A4 EP0705108A4 EP94916845A EP94916845A EP0705108A4 EP 0705108 A4 EP0705108 A4 EP 0705108A4 EP 94916845 A EP94916845 A EP 94916845A EP 94916845 A EP94916845 A EP 94916845A EP 0705108 A4 EP0705108 A4 EP 0705108A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunologic tolerance
- cryptic peptides
- inducing immunologic
- inducing
- cryptic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72832 | 1987-07-13 | ||
US7283293A | 1993-06-02 | 1993-06-02 | |
PCT/AU1994/000292 WO1994027634A1 (en) | 1993-06-02 | 1994-06-01 | Cryptic peptides for use in inducing immunologic tolerance |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0705108A1 EP0705108A1 (en) | 1996-04-10 |
EP0705108A4 true EP0705108A4 (en) | 1997-08-06 |
Family
ID=22110024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94916845A Withdrawn EP0705108A4 (en) | 1993-06-02 | 1994-06-01 | Cryptic peptides for use in inducing immunologic tolerance |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0705108A4 (en) |
JP (1) | JPH09509135A (en) |
AU (1) | AU674584B2 (en) |
CA (1) | CA2164326A1 (en) |
NZ (1) | NZ266739A (en) |
WO (1) | WO1994027634A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759234B1 (en) | 1994-09-02 | 2004-07-06 | Immulogic Pharmaceutical Corporation | Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response |
JPH10505356A (en) * | 1994-09-02 | 1998-05-26 | イミユロジク・フアーマシユーチカル・コーポレーシヨン | Compositions and methods for administration to humans, peptides capable of down-regulating an antigen-specific immune response |
EP0869815A1 (en) * | 1995-09-21 | 1998-10-14 | University Of Utah Research Foundation | Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
JPH09194393A (en) * | 1996-01-22 | 1997-07-29 | Meiji Milk Prod Co Ltd | Induction of immunological tolerance, immunological tolerance inducing food kit and immunological tolerance inducer kit |
GB2352518B (en) * | 1996-03-21 | 2001-04-04 | Circassia Ltd | Screening of compunds for therapeutic activity |
US7097845B2 (en) | 1997-04-23 | 2006-08-29 | Jacob Sten Petersen | Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
US6024961A (en) | 1997-11-14 | 2000-02-15 | Washington University | Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
US6455686B1 (en) | 1998-04-17 | 2002-09-24 | Heska Corporation | Dermatophagoides nucleic acid molecules, proteins and uses thereof |
US7128921B1 (en) | 1998-04-17 | 2006-10-31 | Heska Corporation | Dermatophagoides proteins and fragments thereof |
FR2822709B1 (en) * | 2001-03-30 | 2007-01-19 | Antialis | ANTI-ALLERGIC PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ALLERGEN AND AT LEAST ONE ANTIHISTAMINE COMPOUND |
CA2554337A1 (en) | 2004-02-06 | 2005-08-25 | Greer Laboratories, Inc. | Methods and compositions for dosing of allergens |
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
EP2083856B1 (en) | 2007-08-15 | 2010-09-29 | Circassia Limited | Peptides for desensibilization against allergens |
EP3607973A1 (en) | 2012-06-21 | 2020-02-12 | Northwestern University | Peptide conjugated particles |
PT3033102T (en) | 2013-08-13 | 2019-12-19 | Univ Northwestern | Peptide conjugated particles |
EP3393514A4 (en) | 2015-12-23 | 2019-08-14 | Cour Pharmaceuticals Development Company Inc. | Covalent polymer-antigen conjugated particles |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993008279A1 (en) * | 1991-10-16 | 1993-04-29 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988010297A1 (en) * | 1987-06-17 | 1988-12-29 | Princess Margaret Children's Medical Research Foun | Cloning of mite allergens |
ATE258065T1 (en) * | 1987-06-24 | 2004-02-15 | Brigham & Womens Hospital | TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS |
DK0506785T3 (en) * | 1989-12-20 | 2000-07-24 | Autoimmune Inc | Improved treatment of autoimmune diseases by aerosol administration of autoantigens |
DE69127470T2 (en) * | 1990-03-02 | 1998-02-19 | Autoimmune Inc | REINFORCING REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS |
CA2071896A1 (en) * | 1990-09-06 | 1992-03-07 | Willem Van Eden | Inhibitor of lymphocyte response and immune-related disease |
DK0547164T3 (en) * | 1990-09-07 | 2004-10-25 | Univ California | Methods for diagnosing and treating diabetes |
AU9023791A (en) * | 1990-10-15 | 1992-05-20 | Brigham And Women's Hospital | Treatment of autoimmune diseases by oral administration of autoantigens |
CA2117492C (en) * | 1992-02-28 | 2009-04-07 | Howard L. Weiner | Bystander suppression of autoimmune diseases |
IL105153A (en) * | 1992-03-25 | 1999-12-22 | Immulogic Pharma Corp | Therapeutic compositions comprising peptides derived from human t cell reactive feline protein |
-
1994
- 1994-06-01 EP EP94916845A patent/EP0705108A4/en not_active Withdrawn
- 1994-06-01 NZ NZ266739A patent/NZ266739A/en unknown
- 1994-06-01 CA CA002164326A patent/CA2164326A1/en not_active Abandoned
- 1994-06-01 WO PCT/AU1994/000292 patent/WO1994027634A1/en not_active Application Discontinuation
- 1994-06-01 JP JP7500034A patent/JPH09509135A/en active Pending
- 1994-06-01 AU AU68385/94A patent/AU674584B2/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993008279A1 (en) * | 1991-10-16 | 1993-04-29 | Immulogic Pharmaceutical Corporation | T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
Non-Patent Citations (3)
Title |
---|
H.YSSEL ET AL.: "T cell activation-inducing epitopes of the house dust mite allergen Der pI", JOURNAL OF IMMUNOLOGY, vol. 148, no. 3, 1 February 1992 (1992-02-01), BALTIMORE US, pages 738 - 745, XP002025554 * |
P.JEANNIN ET AL.: "Specific histamine release capacity of peptides selected from the modelized De P I protein, a major allergen of Dermatophagoides pteronyssinus", MOLECULAR IMMUNOLOGY, vol. 29, no. 6, June 1992 (1992-06-01), pages 739 - 749, XP002025555 * |
See also references of WO9427634A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2164326A1 (en) | 1994-12-08 |
EP0705108A1 (en) | 1996-04-10 |
NZ266739A (en) | 1997-07-27 |
AU6838594A (en) | 1994-12-20 |
JPH09509135A (en) | 1997-09-16 |
AU674584B2 (en) | 1997-01-02 |
WO1994027634A1 (en) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9319588D0 (en) | Device for use in oculokinetic perimetry | |
EP0705108A4 (en) | Cryptic peptides for use in inducing immunologic tolerance | |
GB2277450B (en) | Device for use in lithotrity | |
GB2272276B (en) | Improvements in LPG cylinders | |
GB9106157D0 (en) | Improvements in containers | |
IL105153A0 (en) | Peptides useful for tolerization | |
EP0578127A3 (en) | Mechanical in situ curometer | |
GB9224477D0 (en) | Improvements in bodyforms | |
GB2284596B (en) | Improvements in containers | |
GB9409941D0 (en) | Improvements in connecting means | |
GB9206826D0 (en) | Improvements in lighting apparatus | |
LTIP1981A (en) | Pack for use in for horminal replacement therapy | |
ZA944483B (en) | Peptides for use in medicine | |
GB9219126D0 (en) | Improvements in orreries | |
GB8817657D0 (en) | Improvements in containers | |
GB9322693D0 (en) | Improvements in cryogenic apparatus | |
GB2268712B (en) | Improvements in life-jackets | |
GB9222237D0 (en) | Improvements in cryogenic apparatus | |
GB2281252B (en) | Improvements in document storage systems | |
GB9301645D0 (en) | Improvements in cranking systems | |
GB9303723D0 (en) | Peptides for use in alleviating degenerative conditions | |
GB9423830D0 (en) | Improvements in cryogenic apparatus | |
GB9120811D0 (en) | Improvements in cryogenic apparatus | |
GB9307118D0 (en) | Improvements in containers | |
GB9304002D0 (en) | Warming means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19951211 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: TVW TELETHON INSTITUTE FOR CHILD HEALTH RESEARCH |
|
A4 | Supplementary search report drawn up and despatched | ||
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000101 |